Pacira BioSciences, Inc.
PCRX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2012 | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $10.45M | $4.23M | — |
| Net Income | -$16.35M | -$15.28M | — |
| EPS Diluted | -$0.50 | — |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.